Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Azacytidine Plus FLAG for Relapsed or Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE2
Infusion of Allogeneic, 3rd Party CD19-specific T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1
Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE1
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- NA
Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- N/A
A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2